(CA)
ZANSECIMAB(INNE)
ZANSÉCIMAB(INNF)
ZANSECIMAB(INND)
ZANSECIMAB(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS ANGPT2 (ANGIOPOIETIN 2)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-447) [VH (HOMO SAPIENS IGHV1-18*01 (86.7%) -(IGHD) -IGHJ4*01 (93.3%)) CDR-IMGT [8.8.14] (26-33.51-58.97-110) (1-121) -HOMO SAPIENS IGHG4*01, G4V5 H P10,G4V4 CH2 A1.3, A1.2 (CH1 (122-219), HINGE 1-12 S10>P (229) (220-231), CH2 F1.3>A (235), L1.2>A (236) (232-341), CH3 (342- 446), CHS K>DEL (447)) (122-447)], (135-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') [V-KAPPA (HOMO SAPIENS IGKV1-12*01 (83.2%) -IGKJ4*01 (100%)) CDR-IMGT [6.3.9] (27-32.50-52.89-97) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (227-227":230-230")-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO) CELL LINE DERIVED FROM CHO-GSKO, GLYCOFORM ALFA; REC. LIST 85(WHO)
IMMUNOGLOBULIN G4 (229-PROLINE,235-ALANINE,236-ALANINE), ANTI-(HUMAN ANGIOPOIETIN 2) (HUMAN-MUS MUSCULUS MONOCLONAL LY3127804 GAMMA4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LY3127804 KAPPA-CHAIN, DIMER(PCHC)
ZANSECIMABUM(INN)